Embracing Excellence in Prostate and Kidney Cancer

The first European Multidisciplinary Meeting on Urological Cancers will take place in Barcelona, Spain, November 2nd to 4th, 2007. The meeting is co-organized by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO).

Photo: Embracing Excellence in Prostate and Kidney Cancer

EAU, ESMO and ESTRO are proud to organize the first of its kind meeting in Europe. In cooperation with the European Organisation for the Research and Treatment of Cancer (EORTC), the event will provide insight into multidisciplinary approaches to prostate and kidney cancer. World leading experts are going to present their studies and discuss most important topics in the field of urological malignant disorders. Uniting urologists, radiation oncologists and medical oncologists, the extraordinary scientific and multidisciplinary programme will cover a wide spectrum of themes.

The three day event features more than sixty sessions, which aim to optimise diagnostic, therapeutic and preventive interventions directed towards malignant disorders in the urogenital tract and to improve patients’ quality of life. The meeting promises to be an unique event creating exciting opportunities to meet many leading experts associated with oncology and related fields.

For further information about the event and the scientific programme please check the official website:    http://www.emucbarcelona2007.org/

01.10.2007

Read all latest stories

Related articles

Photo

ECCO 15 and 34th ESMO Multidisciplinary Congress unites European Oncology

The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only…

Photo

Breast cancer

Double mastectomy slashes risk - but not for all women

Healthy women who carry a breast cancer-causing mutation in the BRCA1 gene, not only reduce their risk of developing the disease but also their chances of dying from it if they have both breasts…

Related products

Beckman Coulter – Prostate Health Index (phi)

Immunochemistry

Beckman Coulter – Prostate Health Index (phi)

Beckman Coulter, Inc.
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter